← Leaderboards
Ivan King
Vion Pharmaceuticals, Inc.
$850,000
Attributed
$850,000
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$850,000 · 2
By mechanism
R44$750,000 · 1
R43$100,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Vion Pharmaceuticals, Inc.
Same institution · by research overlap
- David G Bermudes$1,071,250
- David Bermudes$141,332
- Michael F Belcourt$166,050
- Chang-Hung Chen$100,000
Others in their field
Top investigators on “Antineoplastics”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,744,647
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Charles A Coltman · Southwest Oncology Group$134,454,243
- Gregory H Reaman · National Childhood Cancer Foundation$112,139,479
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Richard L Schilsky · University Of Chicago$90,728,118
Research focus
AntineoplasticsBiotechnologyGene TherapyLaboratory MouseSalmonellaTransfection /Expression VectorProtein EngineeringAttenuated MicroorganismTumor Necrosis Factor AlphaDisease /Disorder ModelGene MutationTransfectionLipidsGene TargetingNeoplasm /Cancer TherapySalmonella TyphimuriumEpidermal Growth FactorGrowth Factor ReceptorsMolecular CloningNeoplastic CellEnzyme InhibitorsGene Delivery System